home All News open_in_new Full Article
Cybin Completes Enrollment in Phase 2 Study Evaluating CYB004 for the Treatment of Generalized Anxiety Disorder
today 6 d. ago attach_file Economics
attach_file
Economics
attach_file
Other
attach_file
Culture
attach_file
Transport
attach_file
Culture
attach_file
Economics
attach_file
Other
attach_file
Other
attach_file
Sport
attach_file
Economics
attach_file
Economics
attach_file
Politics
attach_file
Other
ID: 2526913647